secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0001558370-23-010719
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris Therapeutics signs new HQ lease for 11,564 sq ft in Wayne, PA
---------------------------------------------------------------------

- Lease with CBCC – Lee Road Acquisitions for space at 701 Lee Road, Wayne, PA.
- Term expected to start Nov 1, 2023, expire March 31, 2029; one five-year extension option.
- Base rent initial $30,114.58/month after 4-month abatement; escalates 2.5% annually.
- Premises is 11,564 rentable square feet; Tenant pays pro rata share of operating expenses and taxes.
- Lease includes early access for furniture and fixtures, standard default and subordination provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000155837023010719/0001558370-23-010719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000155837023010719/acrs-20230526x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer